Security key
05370A108
Atrium Therapeutics, Inc. - Common Stock (RNAM)
CUSIP: 05370A108
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 150,858,761
- Total 13F shares
- 30,963,803
- Share change
- +2,975,798
- Total reported value
- $790,224,311
- Price per share
- $25.52
- Number of holders
- 82
- Value change
- +$74,813,975
- Number of buys
- 49
- Number of sells
- 29
Report period
Q4 2020
Institutions
82
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 05370A108
Recent filing periods:
Top shareholders of RNAM - Atrium Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Atrium Therapeutics, Inc. - Common Stock (RNAM) as of Q4 2020
As of 31 Dec 2020,
Atrium Therapeutics, Inc. - Common Stock (RNAM) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,963,803 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, FMR LLC, Cormorant Asset Management, LP, EcoR1 Capital, LLC, BlackRock Inc., ALETHEA CAPITAL MANAGEMENT, LLC, FEDERATED HERMES, INC., PERCEPTIVE ADVISORS LLC, Matrix Capital Management Company, LP, and BOXER CAPITAL, LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
67
Q4 2020 holders
82
Holder diff
15
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.